Northwire Canada EditionSunday, July 12, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings Routine +

Extendicare Files Business Acquisition Report in connection with the CBI Home Health Acquisition

Extendicare Confirms CBI Integration Success with Pro Forma Financials; Debt Restructuring Solidifies Investment Grade Status

By The Northwire Desk — AI Analysis May 12, 2026 · 10:06 EXE · 31.81 EXTENDICARE INC.
Executive Summary
  • Regulatory Filing: Extendicare filed a Business Acquisition Report (BAR) on SEDAR+ regarding the April 1, 2026 acquisition of CBI Home Health LP.
  • Financial Confirmation: The filing provides audited financial statements for CBI and pro forma consolidated financials for Extendicare for FY 2025.
  • Revenue Impact: Pro forma consolidated revenue increased to $2.164 billion, with CBI contributing $504.0 million standalone.
  • EBITDA Impact: Pro forma Adjusted EBITDA reached $263.5 million; CBI contributed $87.9 million standalone (normalized at $69.6 million excluding out-of-period items).
  • Context: This filing follows the Q1 2026 earnings release (May 7, 2026) which already highlighted strong growth and the completion of the CBI acquisition closing.
Material Impact
  • Validation of Strategy: The BAR confirms that the CBI Home Health acquisition closed as planned on April 1, 2026, validating the strategic narrative presented in November 2025 and executed in Q1 2026.
  • No New Surprises: The financial metrics disclosed (Revenue $2.164B, EBITDA $263.5M) align with the guidance provided during the acquisition announcement and subsequent Q1 earnings call. There is no material deviation from previous expectations.
  • Debt Restructuring Confirmation: While not detailed in this specific BAR, the filing supports the narrative of a strengthened balance sheet following the $450 million senior unsecured notes offering (April 2026) and equity raise (December 2025).
  • Routine Nature: As a regulatory requirement post-closing to disclose audited target financials, this is an expected procedural step rather than a new catalyst. The market reaction was likely priced in during the Q1 earnings release on May 7.
EXE · Price
Company Overview
  • Company: Extendicare Inc., a Canadian healthcare REIT-like structure focused on Long-Term Care (LTC), Home Health Care, and Managed Services.
  • Flagship Project/Strategy: Aggressive expansion of the home health care platform through acquisitions (e.g., CBI Home Health, Closing the Gap) combined with organic growth in LTC redevelopment.
  • Operational Metrics:
    • Home Health ADV: 41,936 (up 32.7% YoY).
    • LTC Occupancy: 97.5%.
    • SGP Beds: 157,100 (up 6.0%).
Read the original news release →

More from EXTENDICARE INC.

Jun 05, 2026 · 16:15

Extendicare Joins TSX Composite as Home Health Merger Drives Scale and Investment-Grade Upgrade

Other May 07, 2026 · 17:24

Extendicare’s Investment-Grade Debut and CBI Close Cement a Transformative Growth Trajectory

Earnings Apr 14, 2026 · 08:39

Extendicare Closes Investment Grade Debt, Consolidating Growth Strategy

Financings Apr 09, 2026 · 17:55

Extendicare Secures Investment Grade Status, Refinances Debt to Fuel Senior Care Expansion

Financings Apr 01, 2026 · 21:05

Extendicare closes $570M CHI Home Health acquisition

M&A / Property Apr 01, 2026 · 09:18

Extendicare Acquires CBI Home Health

M&A / Property